Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT06654856
Eligibility Criteria:
Inclusion Criteria:
* Men or women aged ≥ 19 years
* Subjects with acquired Lumbar Spinal Stenosis who show normal results in the Straight Leg Raising (SLR) test and exhibit intermittent claudication, requiring treatment with Dong-A Opalmon® tab
* Subjects who voluntarily consent to participate in this observational study
Exclusion Criteria:
* Subject for whom the medicinal products administration is contraindicated according to the approved domestic drug information: Pregnant women or those who may be pregnant, Subject with genetic disorders such as galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption
* Subjects considered as unsuitable for participation in this observational study by the principal investigator or sub-investigator
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT06654856
Study Brief:
Protocol Section:
NCT06654856